Open-Label Study of Invega for the Treatment of Mania in Children and Adolescents Ages 6-17 With Bipolar I, Bipolar II, and Bipolar Spectrum Disorder.
Phase of Trial: Phase IV
Latest Information Update: 03 Jul 2012
At a glance
- Drugs Paliperidone (Primary)
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 03 Jul 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Jul 2012 Actual end date (Dec 2009) added as reported by ClinicalTrials.gov.
- 03 Jul 2012 Actual patient number is 17 according to ClinicalTrials.gov.